Gastroenterologia y hepatologia
Efficacy of extended intravenous induction with risankizumab in refractory Crohn's disease.
Marcos A Rodríguez Amado, Aitor Villalba Campano, María Ruiz Sierras, Begoña Ortiz Pérez, Cristina Rubín de Célix, Fernando Bermejo
Published: 202510.1016/j.gastrohep.2025.502635
No abstract available for this study.